Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Biogen (BIIB)

NASDAQ:BIIB

BIIB

Biogen

RESEARCH TOOLSreports

Biogen (BIIB) Ratios

Compare

4,997 Followers

Biogen Ratios

BIIB's free cash flow for Q4 2025 was $0.78. For the 2025 fiscal year, BIIB's free cash flow was decreased by $ and operating cash flow was $-0.03. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	2.68	2.68	1.35	2.00	2.99
Quick Ratio	2.03	2.03	0.90	1.26	2.58
Cash Ratio	0.90	0.90	0.43	0.31	1.04
Solvency Ratio	0.20	0.20	0.20	0.14	0.32
Operating Cash Flow Ratio	0.66	0.66	0.52	0.45	0.42
Short-Term Operating Cash Flow Coverage	27.42	27.42	1.64	10.31	0.00
Net Current Asset Value	$ -2.21B	$ -2.21B	$ -3.88B	$ -5.19B	$ -1.37B
Leverage Ratios
Debt-to-Assets Ratio	0.24	0.24	0.24	0.27	0.27
Debt-to-Equity Ratio	0.38	0.38	0.40	0.50	0.49
Debt-to-Capital Ratio	0.28	0.28	0.28	0.33	0.33
Long-Term Debt-to-Capital Ratio	0.26	0.26	0.21	0.31	0.32
Financial Leverage Ratio	1.61	1.61	1.68	1.81	1.83
Debt Service Coverage Ratio	8.60	9.17	1.36	5.65	11.78
Interest Coverage Ratio	7.02	7.63	9.95	8.49	11.72
Debt to Market Cap	0.25	0.26	0.28	0.19	0.16
Interest Debt Per Share	49.19	49.04	47.22	52.42	47.22
Net Debt to EBITDA	1.27	1.27	1.42	2.65	0.90
Profitability Margins
Gross Profit Margin	70.47%	70.47%	76.12%	74.24%	77.61%
EBIT Margin	22.07%	22.07%	24.00%	19.14%	29.67%
EBITDA Margin	31.60%	31.60%	30.96%	24.17%	34.77%
Operating Profit Margin	19.14%	19.14%	25.74%	21.32%	28.40%
Pretax Profit Margin	14.29%	14.29%	19.70%	13.18%	35.33%
Net Profit Margin	13.18%	13.18%	16.87%	11.81%	29.95%
Continuous Operations Profit Margin	13.18%	13.18%	16.87%	11.81%	29.11%
Net Income Per EBT	92.29%	92.29%	85.63%	89.54%	84.77%
EBT Per EBIT	74.65%	74.65%	76.54%	61.83%	124.41%
Return on Assets (ROA)	4.39%	4.39%	5.82%	4.33%	12.41%
Return on Equity (ROE)	7.28%	7.08%	9.76%	7.85%	22.74%
Return on Capital Employed (ROCE)	7.20%	7.20%	11.06%	8.96%	13.58%
Return on Invested Capital (ROIC)	6.62%	6.62%	8.79%	7.97%	11.19%
Return on Tangible Assets	9.39%	9.39%	13.74%	9.47%	17.97%
Earnings Yield	4.86%	5.01%	7.33%	3.10%	7.57%
Efficiency Ratios
Receivables Turnover	5.25	5.25	5.18	4.68	4.76
Payables Turnover	6.71	6.71	5.45	6.28	4.64
Inventory Turnover	1.34	1.34	0.94	1.00	1.69
Fixed Asset Turnover	2.95	2.95	2.74	2.64	2.75
Asset Turnover	0.33	0.33	0.34	0.37	0.41
Working Capital Turnover Ratio	1.74	2.60	3.62	1.98	2.02
Cash Conversion Cycle	288.20	288.20	392.19	383.96	213.29
Days of Sales Outstanding	69.46	69.46	70.50	77.93	76.65
Days of Inventory Outstanding	273.16	273.16	388.71	364.14	215.38
Days of Payables Outstanding	54.43	54.43	67.02	58.11	78.74
Operating Cycle	342.63	342.63	459.21	442.07	292.03
Cash Flow Ratios
Operating Cash Flow Per Share	15.03	15.03	19.74	10.69	9.53
Free Cash Flow Per Share	14.58	13.98	17.27	8.54	7.87
CapEx Per Share	0.45	1.05	2.47	2.15	1.65
Free Cash Flow to Operating Cash Flow	0.97	0.93	0.87	0.80	0.83
Dividend Paid and CapEx Coverage Ratio	33.40	14.33	7.99	4.97	5.76
Capital Expenditure Coverage Ratio	33.40	14.33	7.99	4.97	5.76
Operating Cash Flow Coverage Ratio	0.32	0.32	0.43	0.21	0.21
Operating Cash Flow to Sales Ratio	0.22	0.22	0.30	0.16	0.14
Free Cash Flow Yield	8.03%	7.94%	11.29%	3.30%	2.84%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	20.58	19.96	13.65	32.25	13.21
Price-to-Sales (P/S) Ratio	2.71	2.63	2.30	3.81	3.96
Price-to-Book (P/B) Ratio	1.46	1.41	1.33	2.53	3.00
Price-to-Free Cash Flow (P/FCF) Ratio	12.45	12.59	8.86	30.30	35.17
Price-to-Operating Cash Flow Ratio	12.07	11.71	7.75	24.20	29.07
Price-to-Earnings Growth (PEG) Ratio	-1.05	-0.95	0.34	-0.52	0.13
Price-to-Fair Value	1.46	1.41	1.33	2.53	3.00
Enterprise Value Multiple	9.86	9.60	8.86	18.40	12.28
Enterprise Value	30.57B	29.76B	26.54B	43.73B	43.43B
EV to EBITDA	9.86	9.60	8.86	18.40	12.28
EV to Sales	3.12	3.03	2.74	4.45	4.27
EV to Free Cash Flow	14.29	14.51	10.55	35.39	37.96
EV to Operating Cash Flow	13.87	13.50	9.23	28.27	31.37
Tangible Book Value Per Share	17.64	17.64	3.75	1.50	39.84
Shareholders’ Equity Per Share	124.45	124.45	114.73	102.28	92.21
Tax and Other Ratios
Effective Tax Rate	0.08	0.08	0.14	0.10	0.18
Revenue Per Share	66.88	66.88	66.41	67.97	70.02
Net Income Per Share	8.82	8.82	11.20	8.02	20.97
Tax Burden	0.92	0.92	0.86	0.90	0.85
Interest Burden	0.65	0.65	0.82	0.69	1.19
Research & Development to Revenue	0.20	0.20	0.26	0.27	0.26
SG&A to Revenue	0.07	0.25	0.24	0.25	0.23
Stock-Based Compensation to Revenue	0.02	0.03	0.03	0.03	0.02
Income Quality	1.71	1.71	1.76	1.33	0.47

Currency in USD